Liu et al. found that blocking or deleting SPP1 in macrophages disrupts the tumor immune barrier, increases cytotoxic T cell infiltration, and improves anti-PD-1 therapy effectiveness in a mouse liver cancer model [54]. The gene discussed is SPP1; the disease is neoplasm.